Ignite Creation Date:
2025-12-26 @ 11:08 AM
Ignite Modification Date:
2026-02-27 @ 12:48 AM
Study NCT ID:
NCT00647712
Status:
COMPLETED
Last Update Posted:
2009-09-25
First Post:
2008-03-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fasting Study of Divalproex Sodium Extended-Release Tablets 500 mg to Depakote ER® Tablets 500 mg
Sponsor:
Mylan Pharmaceuticals Inc
Organization:
Organization Data
Organization:
Class:
UNKNOWN
Study ID:
DIVA-0380
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Will Sullvan, Global Head of Product Risk and Safety Management
Old Organization:
Mylan Inc.